Danaher
Logotype for Danaher Corporation

Danaher (DHR) investor relations material

Danaher Jefferies Global Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Danaher Corporation
Jefferies Global Healthcare Conference summary17 Nov, 2026

Strategic priorities and commercial execution

  • Ambition: higher, sustainable profitable core growth and unambiguous share gain; priorities are commercial excellence, innovation, talent and capital allocation.

  • Commercial focus includes stronger funnel management and account plans, plus a key-account layer connecting customers with multiple operating companies.

  • Connected diagnostic selling has created several hundred million dollars of incremental opportunity.

  • Innovation strategy will direct organic R&D toward the strongest growth opportunities; annual innovation spending is ~$1.7B, viewed as the right level, with added science and technology talent.

  • In diagnostics, focused innovation priorities increased forecasted growth from innovation by 80%.

Growth playbook and innovation opportunities

  • Diagnostics revenue grew from $6B in 2017 to $11B, with 3x the operating profit; core growth ex-respiratory in China more than doubled over the last handful of years.

  • Leica Biosystems improved from mid-single-digit to high-single-digit growth through stronger commercial execution, including funnel management and account planning.

  • Leica Biosystems is investing in companion diagnostics and pharma services; its quantitative companion diagnostics pipeline is growing, with material P&L impact expected only after development stages.

  • Priority innovation areas include blood-based Alzheimer’s biomarkers, oncology, AI drug discovery and process intensification; Alzheimer’s testing could become a $5B market in 10 years, with 150+ disease-modifying therapies in the pipeline.

Capital allocation and M&A

  • M&A remains the capital deployment priority, focused on differentiated growth and strengthening the three platforms; more than $11B was deployed this year, including Masimo and StatLab.

  • Masimo and StatLab are expected to deliver high-single-digit ROICs by year five or earlier; buybacks remain opportunistic and the dividend is a commitment.

  • A lesson from Aldevron was to assess technology and product adoption curves thoroughly after cell and gene therapy adoption timing was misjudged.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Danaher earnings date

Logotype for Danaher Corporation
Q4 202627 Jan, 2027
Danaher
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next Danaher earnings date

Logotype for Danaher Corporation
Q4 202627 Jan, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Life Science Suppliers

Established in 1969, Danaher Corporation first started out in the real estate investment field to then move on to and in time become a notable player in the science and technology sector. Headquartered in Washington, D.C., Danaher's portfolio encompasses life sciences, diagnostics, environmental, and applied solutions. The company provides tools and solutions that cater to a wide range of professional and institutional needs and has grown through both the organic expansion of its operations, but also through hundreds of acquisitions over the years.

What They Do

Danaher is a diversified company, primarily operating in life sciences and various related fields. Under the Life Sciences umbrella, Danaher engages in a wide array of research and development activities, providing solutions for biological research and pharmaceutical drug discovery. With equipment and tools that facilitate the understanding of complex biological matters, Danaher supports projects in genomics, proteomics, and cellular analysis. In diagnostics, the corporation delivers a suite of analytical instruments, reagents, consumables, software, and services that hospitals, physicians, and diagnostic labs employ to diagnose diseases and ailments. The company is also active in Environmental & Applied Solutions. This segment focuses on products that ensure environmental safety and quality and covers areas such as water quality analysis and product identification. Danaher competes with companies operating in the same industry as them, such as Thermo Fisher and Illumina.

Danaher Business System

At the heart of Danaher Corporation's philosophy lies the Danaher Business System (DBS), a unique and continuously evolving system that drives every aspect of the conglomerate's operations. Stemming from the foundational principles of the Toyota Production System, DBS has been modified to fit Danaher's business operations.

The system focuses on providing the highest quality, delivery, and value by enhancing customer satisfaction and driving sustainable growth. Key components of DBS include lean manufacturing, leadership development, and problem-solving. By applying these principles, Danaher aims to minimize waste and enhance productivity. Furthermore, DBS fosters innovation by emphasizing the importance of understanding market needs and acting on them swiftly.

Acquiring for the Long Term

Danaher Corporation's acquisition strategy is a pivotal component of its growth. Through deliberate and strategic purchases, primarily in the life sciences, diagnostics, and environmental sectors, Danaher expands its product and service offerings. Each acquisition is meticulously chosen to align with and complement their existing portfolio. Instead of short-term gains, Danaher focuses on long-term value, using DBS as a tool to optimize and enhance the performance of its new assets.